Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 20/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 10/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.86 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.86 |
| ▸ | HSD3B2 | P26439 | 1/20 | 0.86 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL955579 | 1.00 | HSD11B1 (1.00) | HSD11B1CYP3A4CYP2C9CYP2C19HSD3B2 | |
| SCHEMBL955581 | 1.00 | HSD11B1 (1.00) | HSD11B1CYP3A4CYP2C9CYP2C19HSD3B2 | |
| SCHEMBL3643918 | 0.95 | HSD11B1 (0.91) | HSD11B1CYP3A4CYP2C9CYP2C19HSD3B2 | |
| SCHEMBL15949359 | 0.95 | HSD11B1 (0.91) | HSD11B1CYP3A4CYP2C9CYP2C19HSD3B2 | |
| SCHEMBL957398 | 0.95 | HSD11B1 (1.00) | HSD11B1CYP3A4CYP2C9CYP2C19HSD3B2 | |
| SCHEMBL957397 | 0.95 | HSD11B1 (1.00) | HSD11B1CYP3A4CYP2C9CYP2C19HSD3B2 | |
| SCHEMBL3644704 | 0.93 | HSD11B1 (1.00) | HSD11B1CYP3A4CYP2C9CYP2C19HSD3B2 | |
| SCHEMBL734885 | 0.93 | HSD11B1 (1.00) | HSD11B1CYP3A4CYP2C9CYP2C19HSD3B2 | |
| SCHEMBL15368374 | 0.93 | HSD11B1 (0.86) | HSD11B1CYP3A4CYP2C9CYP2C19HSD3B2 | |
| SCHEMBL956892 | 0.93 | HSD11B1 (1.00) | HSD11B1CYP3A4CYP2C9CYP2C19HSD3B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2183228-B1 | CYCLIC INHIBITORS OF 11ß -HYDROXYSTERIOD DEHYDROGENASE 1 | VITAE PHARMACEUTICALS INC (US) | 2014-08-20 | — | — | EP | disclosed |